TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NARGUND, Ravi, MARCANTONIO, Karen, PALANI, Anandan, BROCKUNIER, Linda, L, GUO, Tao, HE, Shuwen, ZORN, Nicolas, XIAO, Dong, LI, Peng, PENG, Xuanjia, DAI, Xing, LIU, Hong
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NARGUND, Ravi
MARCANTONIO, Karen
PALANI, Anandan
BROCKUNIER, Linda, L
GUO, Tao
HE, Shuwen
ZORN, Nicolas
XIAO, Dong
LI, Peng
PENG, Xuanjia
DAI, Xing
LIU, Hong
description The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2953456B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2953456B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2953456B13</originalsourceid><addsrcrecordid>eNqNyrEKwjAUheEsDqK-w30BB60VHGN6QgImKcnt4CClSJxEC_X9sQEfwOl8B_6luDE4SnVVF6vIgBFDOSAVXBs63ySSviEHNmF20NQlEBtEzNYhFhNHSHbwXAKDVrJlm0itxeIxPKe8-e1KkAYrs83ju8_TONzzK396tPtTXR3q43lX_ZF8AYoWMi0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C</title><source>esp@cenet</source><creator>NARGUND, Ravi ; MARCANTONIO, Karen ; PALANI, Anandan ; BROCKUNIER, Linda, L ; GUO, Tao ; HE, Shuwen ; ZORN, Nicolas ; XIAO, Dong ; LI, Peng ; PENG, Xuanjia ; DAI, Xing ; LIU, Hong</creator><creatorcontrib>NARGUND, Ravi ; MARCANTONIO, Karen ; PALANI, Anandan ; BROCKUNIER, Linda, L ; GUO, Tao ; HE, Shuwen ; ZORN, Nicolas ; XIAO, Dong ; LI, Peng ; PENG, Xuanjia ; DAI, Xing ; LIU, Hong</creatorcontrib><description>The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190522&amp;DB=EPODOC&amp;CC=EP&amp;NR=2953456B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190522&amp;DB=EPODOC&amp;CC=EP&amp;NR=2953456B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NARGUND, Ravi</creatorcontrib><creatorcontrib>MARCANTONIO, Karen</creatorcontrib><creatorcontrib>PALANI, Anandan</creatorcontrib><creatorcontrib>BROCKUNIER, Linda, L</creatorcontrib><creatorcontrib>GUO, Tao</creatorcontrib><creatorcontrib>HE, Shuwen</creatorcontrib><creatorcontrib>ZORN, Nicolas</creatorcontrib><creatorcontrib>XIAO, Dong</creatorcontrib><creatorcontrib>LI, Peng</creatorcontrib><creatorcontrib>PENG, Xuanjia</creatorcontrib><creatorcontrib>DAI, Xing</creatorcontrib><creatorcontrib>LIU, Hong</creatorcontrib><title>TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C</title><description>The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAUheEsDqK-w30BB60VHGN6QgImKcnt4CClSJxEC_X9sQEfwOl8B_6luDE4SnVVF6vIgBFDOSAVXBs63ySSviEHNmF20NQlEBtEzNYhFhNHSHbwXAKDVrJlm0itxeIxPKe8-e1KkAYrs83ju8_TONzzK396tPtTXR3q43lX_ZF8AYoWMi0</recordid><startdate>20190522</startdate><enddate>20190522</enddate><creator>NARGUND, Ravi</creator><creator>MARCANTONIO, Karen</creator><creator>PALANI, Anandan</creator><creator>BROCKUNIER, Linda, L</creator><creator>GUO, Tao</creator><creator>HE, Shuwen</creator><creator>ZORN, Nicolas</creator><creator>XIAO, Dong</creator><creator>LI, Peng</creator><creator>PENG, Xuanjia</creator><creator>DAI, Xing</creator><creator>LIU, Hong</creator><scope>EVB</scope></search><sort><creationdate>20190522</creationdate><title>TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C</title><author>NARGUND, Ravi ; MARCANTONIO, Karen ; PALANI, Anandan ; BROCKUNIER, Linda, L ; GUO, Tao ; HE, Shuwen ; ZORN, Nicolas ; XIAO, Dong ; LI, Peng ; PENG, Xuanjia ; DAI, Xing ; LIU, Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2953456B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>NARGUND, Ravi</creatorcontrib><creatorcontrib>MARCANTONIO, Karen</creatorcontrib><creatorcontrib>PALANI, Anandan</creatorcontrib><creatorcontrib>BROCKUNIER, Linda, L</creatorcontrib><creatorcontrib>GUO, Tao</creatorcontrib><creatorcontrib>HE, Shuwen</creatorcontrib><creatorcontrib>ZORN, Nicolas</creatorcontrib><creatorcontrib>XIAO, Dong</creatorcontrib><creatorcontrib>LI, Peng</creatorcontrib><creatorcontrib>PENG, Xuanjia</creatorcontrib><creatorcontrib>DAI, Xing</creatorcontrib><creatorcontrib>LIU, Hong</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NARGUND, Ravi</au><au>MARCANTONIO, Karen</au><au>PALANI, Anandan</au><au>BROCKUNIER, Linda, L</au><au>GUO, Tao</au><au>HE, Shuwen</au><au>ZORN, Nicolas</au><au>XIAO, Dong</au><au>LI, Peng</au><au>PENG, Xuanjia</au><au>DAI, Xing</au><au>LIU, Hong</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C</title><date>2019-05-22</date><risdate>2019</risdate><abstract>The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2953456B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T09%3A27%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NARGUND,%20Ravi&rft.date=2019-05-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2953456B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true